Terms: = Breast cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677
241 results:
1. Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection.
Raj-Kumar PK; Lin X; Liu T; Sturtz LA; Gritsenko MA; Petyuk VA; Sagendorf TJ; Deyarmin B; Liu J; Praveen-Kumar A; Wang G; McDermott JE; Shukla AK; Moore RJ; Monroe ME; Webb-Robertson BM; Hooke JA; Fantacone-Campbell L; Mostoller B; Kvecher L; Kane J; Melley J; Somiari S; Soon-Shiong P; Smith RD; Mural RJ; Rodland KD; Shriver CD; Kovatich AJ; Hu H
Breast Cancer Res; 2024 May; 26(1):76. PubMed ID: 38745208
[TBL] [Abstract] [Full Text] [Related]
2. Thyroid abnormalities identified on CT screening for lung cancer.
van Gerwen M; Ma T; Yip R; Choi C; Paksashvili N; Yankelevitz D; Henschke C
Clin Imaging; 2024 Jun; 110():110162. PubMed ID: 38691910
[TBL] [Abstract] [Full Text] [Related]
3. Photobiomodulation therapy moderates cancer cachexia-associated muscle wasting through activating PI3K/AKT/foxo3a pathway.
Li Y; Chen Y; Liao Y; Huang T; Tang Q; He C; Xu L; Chang H; Li H; Liu Q; Lai D; Xia Q; Zou Z
Apoptosis; 2024 Jun; 29(5-6):663-680. PubMed ID: 38598070
[TBL] [Abstract] [Full Text] [Related]
4. Oncolytic adenovirus encoding apolipoprotein A1 suppresses metastasis of triple-negative breast cancer in mice.
Dong J; Kong L; Wang S; Xia M; Zhang Y; Wu J; Yang F; Zuo S; Wei J
J Exp Clin Cancer Res; 2024 Apr; 43(1):102. PubMed ID: 38566092
[TBL] [Abstract] [Full Text] [Related]
5. Carbon-Coated Iron Oxide Nanoparticles Promote Reductive Stress-Mediated Cytotoxic Autophagy in Drug-Induced Senescent breast cancer Cells.
Lewińska A; Radoń A; Gil K; Błoniarz D; Ciuraszkiewicz A; Kubacki J; Kądziołka-Gaweł M; Łukowiec D; Gębara P; Krogul-Sobczak A; Piotrowski P; Fijałkowska O; Wybraniec S; Szmatoła T; Kolano-Burian A; Wnuk M
ACS Appl Mater Interfaces; 2024 Mar; 16(12):15457-15478. PubMed ID: 38483821
[TBL] [Abstract] [Full Text] [Related]
6. Circ-foxo3 inhibits triple-negative breast cancer growth and metastasis via regulating WHSC1-H3K36me2-Zeb2 axis.
Chen D; Zeng S; Qiu H; Yang M; Lin X; Lv X; Li P; Weng S; Kou S; Luo K; Liu Z; Yi Y; Liu H
Cell Signal; 2024 May; 117():111079. PubMed ID: 38341124
[TBL] [Abstract] [Full Text] [Related]
7. foxo3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant breast cancer Cells Restoring Tamoxifen Sensitivity.
Fiorillo M; Ricci E; Fava M; Longobucco C; Sotgia F; Rizza P; Lanzino M; Bonofiglio D; Conforti FL; Catalano S; Barone I; Morelli C; Aquila S; Lisanti MP; Sisci D
Cells; 2023 Dec; 12(24):. PubMed ID: 38132097
[TBL] [Abstract] [Full Text] [Related]
8. FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling.
Xing X; Liu M; Wang X; Guo Q; Wang H; Wang W
J Cell Mol Med; 2024 Jan; 28(1):e18041. PubMed ID: 37987202
[TBL] [Abstract] [Full Text] [Related]
9. Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/foxo3/FOXM1 axis in breast cancer cells.
Li H; Tang X; Sun Z; Qu Z; Zou X
Biomol Biomed; 2024 May; 24(3):560-574. PubMed ID: 37976368
[TBL] [Abstract] [Full Text] [Related]
10. Stomatin-like protein-2 contributes the migration and invasion of breast cancer cells via regulating ERK/foxo3a signaling pathway.
Wu S; Zhao L; Li Q
Chin J Physiol; 2023; 66(4):257-265. PubMed ID: 37635485
[TBL] [Abstract] [Full Text] [Related]
11. Role of circ-foxo3 and miR-23a in radiosensitivity of breast cancer.
Abdollahi E; Mozdarani H; Alizadeh BZ
Breast Cancer; 2023 Sep; 30(5):714-726. PubMed ID: 37222952
[TBL] [Abstract] [Full Text] [Related]
12. Molecular Pathology of Micropapillary Carcinomas: Is Characteristic Morphology Related to Molecular Mechanisms?
Sagnak Yilmaz Z; Sarioglu S
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):267-277. PubMed ID: 37036419
[TBL] [Abstract] [Full Text] [Related]
13. Ras interacting protein 1 facilitated proliferation and invasion of diffuse large B-cell lymphoma cells.
Xing X; Wang X; Liu M; Guo Q; Wang H
Cancer Biol Ther; 2023 Dec; 24(1):2193114. PubMed ID: 36967521
[TBL] [Abstract] [Full Text] [Related]
14. Could be foxo3a, miR-96-5p and miR-182-5p useful for Brazilian women with luminal A and triple negative breast cancers prognosis and target therapy?
Mendes DCC; Filho CMCC; Garcia N; Ricci MD; Soares JM; Carvalho KC; Baracat EC
Clinics (Sao Paulo); 2023; 78():100155. PubMed ID: 36681070
[TBL] [Abstract] [Full Text] [Related]
15. SN-38, an active metabolite of irinotecan, enhances anti-PD-1 treatment efficacy in head and neck squamous cell carcinoma.
Lee YM; Chen YH; Ou DL; Hsu CL; Liu JH; Ko JY; Hu MC; Tan CT
J Pathol; 2023 Apr; 259(4):428-440. PubMed ID: 36641765
[TBL] [Abstract] [Full Text] [Related]
16. The Pan-cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance.
Xie J; Zhang J; Tian W; Zou Y; Tang Y; Zheng S; Wong CW; Deng X; Wu S; Chen J; Mo Y; Xie X
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555288
[TBL] [Abstract] [Full Text] [Related]
17. The Role of miRNA-182 and foxo3 Expression in breast cancer.
Kandil NS; Kandil LS; Mohamed R; Selima M; El Nemr M; Barakat AR; Alwany YN
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3361-3370. PubMed ID: 36308360
[TBL] [Abstract] [Full Text] [Related]
18. Genistein-induced mitochondrial dysfunction and foxo3a/PUMA expression in non-small lung cancer cells.
Chan L; Pang Y; Wang Y; Zhu D; Taledaohan A; Jia Y; Zhao L; Wang W
Pharm Biol; 2022 Dec; 60(1):1876-1883. PubMed ID: 36200643
[TBL] [Abstract] [Full Text] [Related]
19. Identifying Patients Whose Symptoms Are Underrecognized During Treatment With breast Radiotherapy.
Jagsi R; Griffith KA; Vicini F; Boike T; Dominello M; Gustafson G; Hayman JA; Moran JM; Radawski JD; Walker E; Pierce L;
JAMA Oncol; 2022 Jun; 8(6):887-894. PubMed ID: 35446337
[TBL] [Abstract] [Full Text] [Related]
20. Chemotherapy-induced adenosine A2B receptor expression mediates epigenetic regulation of pluripotency factors and promotes breast cancer stemness.
Lan J; Wei G; Liu J; Yang F; Sun R; Lu H
Theranostics; 2022; 12(6):2598-2612. PubMed ID: 35401817
[No Abstract] [Full Text] [Related]
[Next]
